Search details
1.
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.
Blood
; 143(24): 2490-2503, 2024 Jun 13.
Article
in English
| MEDLINE | ID: mdl-38493481
2.
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.
Blood Adv
; 8(9): 2312-2325, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38295283
3.
Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.
Hemasphere
; 7(5): e885, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37153874
Results
1 -
3
de 3
1
Next >
>>